| How to Control Asthma with Personalized Management: Where Do We Stand Now? | |
| Yao Y; Tao F; Jiang S; Tang R; Wang M; Sun J. | |
| 刊名 | Curr Drug Metab
 |
| 2018 | |
| 关键词 | Asthma GWAS. anti-leukotriene modifiers b-adrenergic receptor agonists candidate gene approach inhaled corticosteroid pharmacogenetics |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2154841 |
| 专题 | 安徽大学 |
| 作者单位 | 1.School of Life Sciences, Anhui University, 230601, Hefei. China. 2.Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 100730, Beijing. China. |
| 推荐引用方式 GB/T 7714 | Yao Y,Tao F,Jiang S,et al. How to Control Asthma with Personalized Management: Where Do We Stand Now?[J]. Curr Drug Metab,2018. |
| APA | Yao Y,Tao F,Jiang S,Tang R,Wang M,&Sun J..(2018).How to Control Asthma with Personalized Management: Where Do We Stand Now?.Curr Drug Metab. |
| MLA | Yao Y,et al."How to Control Asthma with Personalized Management: Where Do We Stand Now?".Curr Drug Metab (2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论